Type 1 Diabetes Trial, Recruiting (NCT07050888)

Type 1 Diabetes Trial, Recruiting NCT07050888 Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) Condition: Type 1 Diabetes

Printed from Voxsanity (voxsanity.com.au) — NCT07050888 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Type 1 Diabetes

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have been diagnosed with type 1 diabetes by their own doctor or specialist.
People whose blood sugar levels have been in the healthy target range less than 80% of the time over the four weeks before the screening visit.

Who may not be able to join:

People who have used fibre supplements in the month before screening or are currently taking them.
People who have taken antibiotics in the three months before screening, or who take antibiotics during the study.
People who have an active infection at the time of a study visit.
People who are unable or unwilling to provide stool or urine samples.
People who have used illicit drugs (such as MDMA, amphetamines, cocaine, heroin, or GHB) in the three months before screening, or who use them during the study period.
People who are unable or unwilling to give informed consent to take part in the study.
People who do not have a large bowel — for example, those who have a colostomy.
People who have active inflammatory bowel disease.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Nordin Hanssen, Principal Investigator, Amsterdam UMC

Phone: +31 20-5669111

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07050888

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase: Not Applicable

Status: Recruiting

Condition: Type 1 Diabetes

Trial contact: +31 20-5669111

More information: https://clinicaltrials.gov/study/NCT07050888

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have been diagnosed with type 1 diabetes by their own doctor or specialist.
People whose blood sugar levels have been in the healthy target range less than 80% of the time over the four weeks before the screening visit.

Who may not be able to join:

People who have used fibre supplements in the month before screening or are currently taking them.
People who have taken antibiotics in the three months before screening, or who take antibiotics during the study.
People who have an active infection at the time of a study visit.
People who are unable or unwilling to provide stool or urine samples.
People who have used illicit drugs (such as MDMA, amphetamines, cocaine, heroin, or GHB) in the three months before screening, or who use them during the study period.
People who are unable or unwilling to give informed consent to take part in the study.
People who do not have a large bowel — for example, those who have a colostomy.
People who have active inflammatory bowel disease.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Registry

ClinicalTrials.gov

Start date

9 May 2025

Est. completion

1 April 2027

Where this trial is recruiting

🇳🇱 Netherlands

Primary endpoints

Time in range

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov